Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
In this region, Global cancer diagnostics is projected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are the growing aging population worldwide, government initiatives for funding, and awareness about cancer.
The key market players for Global Cancer Diagnostics Market are listed below:Type Application Technology End User Geography
The global cancer diagnostics market is segmented on the basis of technology, application, and geography. The global cancer diagnostics market is segmented into two types, platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohisto chemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography, and ultrasound.
On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the Global cancer diagnostics market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Global cancer diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are the growing aging population worldwide, government initiatives for funding, and awareness about cancer.
The key market players for Global Cancer Diagnostics Market are listed below:
- GE Healthcare
- Siemens Healthcare
- GmbH
- Hologic, Inc,
- Becton,
- Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Roche Diagnostics,
- Abbott,
- QIAGEN.
The global cancer diagnostics market is segmented on the basis of technology, application, and geography. The global cancer diagnostics market is segmented into two types, platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohisto chemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography, and ultrasound.
On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the Global cancer diagnostics market is segmented into 11 geographical regions, such as,
- North America,
- Europe,
- Asia-Pacific,
- Latin America,
- Rest of the World
The report covers the present scenario and the growth prospects of the Global cancer diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL CANCER DIAGNOSTICS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWTH OF AGING POPULATION AND RISING PREVALENCE OF CANCER
3.1.2. GOVERNMENT INITIATIVES FOR FUNDING AND AWARENESS ABOUT CANCER
3.1.3. KEY PLAYERS FOCUSING ON STRATEGIC DECISIONS TO GAIN MARKET SHARE
3.1.4. INCREASING PREVELANCE OF CANCER
3.2. RESTRAINTS
3.2.1. STRINGENT REULATIONS IMPOSED BY INTERNATIONAL AND LOCAL AUTHORITIES
3.2.2. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS
3.3. OPPORTUNITIES
3.3.1. NANOTECHNOLOGY: FORTHCOMING REVOLUTION IN CANCER DIAGNOSIS
3.3.2. ARTIFICIAL INTELLIGENCE AND THE IMMINENT HEALTH REVOLUTION
3.3.3. GROWING MEDICAL TOURISM IN ASIA
3.4. CHALLENGES
3.4.1. INCREASING RIVALRY AMONG THE COMPETITORS
3.4.2. POOR ACCESS TO CANCER DETECTION AND HIGH TREATMENT COCTS IN LOWER INCOME COUNTRIES
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.2. PLATFORM BASED
6.2.1. POLYMERASE CHAIN REACTION(PCR)
6.2.2. IN SITU HYBRIDIZATION (ISH)
6.2.3. IMMUNOHISTOCHEMISTRY(IHC)
6.2.4. NEXT GENERATION SEQUENCING (NGS)
6.2.5. DNA MICROARRAYS
6.2.6. FLOW CYTOMETRY
6.3. INSTRUMENT BASED
6.3.1. IMAGING
6.3.1.1. MAGENTIC RESONANCE IMAGING (MRI)
6.3.1.2. CT(COMPUTED TOMOGRAPHY)
6.3.1.3. POSITRON EMISSION TOMOGRAPHY- COMPUTED TOMOGRAPHY (PET-CT)
6.3.1.4. MAMMOGRAPHY
6.3.1.5. ULTRASOUND
6.3.2. BIOPSY
7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
7.5. MELANOMA
7.6. OTHERS
8. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET
8.2.1. U.S.CANCER DIAGNOSTICS MARKET
8.2.2. CANADA CANCER DIAGNOSTICS MARKET
8.2.3. MEXICO CANCER DIAGNOSTICS MARKET
8.3. EUROPE CANCER DIAGNOSTICS MARKET
8.3.1. GERMANY CANCER DIAGNOSTICS MARKET
8.3.2. FRANCE CANCER DIAGNOSTICS MARKET
8.3.3. U.K. CANCER DIAGNOSTICS MARKET
8.3.4. ITALY CANCER DIAGNOSTICS MARKET
8.3.5. SPAIN CANCER DIAGNOSTICS MARKET
8.3.6. RUSSIA CANCER DIAGNOSTICS MARKET
8.3.7. TURKEY CANCER DIAGNOSTICS MARKET
8.3.8. BELGIUM CANCER DIAGNOSTICS MARKET
8.3.9. NETHERLANDS CANCER DIAGNOSTICS MARKET
8.3.10. SWITZERLAND CANCER DIAGNOSTICS MARKET
8.3.11. REST OF EUROPE CANCER DIAGNOSTICS MARKET
8.4. APAC CANCER DIAGNOSTICS MARKET
8.4.1. JAPAN CANCER DIAGNOSTICS MARKET
8.4.2. CHINA CANCER DIAGNOSTICS MARKET
8.4.3. INDIA CANCER DIAGNOSTICS MARKET
8.4.4. SOUTH KOREA CANCER DIAGNOSTICS MARKET
8.4.5. AUSTRALIA CANCER DIAGNOSTICS MARKET
8.4.6. THAILAND CANCER DIAGNOSTICS MARKET
8.4.7. SINGAPORE CANCER DIAGNOSTICS MARKET
8.4.8. MALAYSIA CANCER DIAGNOSTICS MARKET
8.4.9. INDONESIA CANCER DIAGNOSTICS MARKET
8.4.10. PHILIPPINES CANCER DIAGNOSTICS MARKET
8.4.11. REST OF APAC CANCER DIAGNOSTICS MARKET
8.5. SOUTH AMERICA CANCER DIAGNOSTICS MARKET
8.5.1. BRAZIL CANCER DIAGNOSTICS MARKET
8.5.2. REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET
8.6. MEA CANCER DIAGNOSTICS MARKET
8.6.1. SOUTH AFRICA CANCER DIAGNOSTICS MARKET
8.6.2. REST OF MEA CANCER DIAGNOSTICS MARKET
9. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE
9.1. COMPANY SHARE ANALYSIS: GLOBAL CANCER DIAGNOSTICS IMAGING MARKET
9.2. COMPANY SHARE ANALYSIS: GLOBAL CANCER DIAGNOSTICS PLATFORM BASED MARKET
10. COMPANY PROFILES
10.1. C. R. BARD, INC.
10.1.1. COMPANY OVERVIEW
10.1.2. REVENUE ANALYSIS
10.1.3. PRODUCT PORTFOLIO
10.1.4. RECENT DEVELOPMENTS
10.2. ILLUMINA, INC.
10.2.1. COMPANY OVERVIEW
10.2.2. REVENUE ANALYSIS
10.2.3. RECENT DEVELOPMENTS
10.2.4. PRODUCT PORTFOLIO
10.3. QIAGEN
10.3.1. COMPANY OVERVIEW
10.3.2. REVENUE ANALYSIS
10.3.3. RECENT DEVELOPMENTS
10.3.4. PRODUCT PORTFOLIO
10.4. ABBOTT
10.4.1. COMPANY OVERVIEW
10.4.2. REVENUE ANALYSIS
10.4.3. RECENT DEVELOPMENTS
10.4.4. PRODUCT PORTFOLIO
10.5. SIEMENS HEALTHCARE GMBH
10.5.1. COMPANY OVERVIEW
10.5.2. REVENUE ANALYSIS
10.5.3. RECENT DEVELOPMENTS
10.5.4. PRODUCT PORTFOLIO
10.6. AGILENT TECHNOLOGIES
10.6.1. COMPANY OVERVIEW
10.6.2. REVENUE ANALYSIS
10.6.3. PRODUCT PORTFOLIO
10.6.4. RECENT DEVELOPMENTS
10.7. THERMO FISHER SCIENTIFIC INC.
10.7.1. COMPANY OVERVIEW
10.7.2. REVENUE ANALYSIS
10.7.3. PRODUCT PORTFOLIO
10.7.4. RECENT DEVELOPMENTS
10.8. BECTON, DICKINSON AND COMPANY
10.8.1. COMPANY OVERVIEW
10.8.2. REVENUE ANALYSIS
10.8.3. PRODUCT PORTFOLIO
10.8.4. RECENT DEVELOPMENTS
10.9. GE HEALTHCARE
10.9.1. COMPANY OVERVIEW
10.9.2. REVENUE ANALYSIS
10.9.3. PRODUCT PORTFOLIO
10.9.4. RECENT DEVELOPMENTS
10.10. F. HOFFMANN-LA ROCHE LTD
10.10.1. COMPANY OVERVIEW
10.10.2. REVENUE ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. RECENT DEVELOPMENTS
10.11. HOLOGIC INC.
10.11.1. COMPANY OVERVIEW
10.11.2. REVENUE ANALYSIS
10.11.3. RECENT DEVELOPMENTS
10.11.4. PRODUCT PORTFOLIO
10.12. KONINKLIJHE PHILIPS N.V.
10.12.1. COMPANY OVERVIEW
10.12.2. REVENUE ANALYSIS
10.12.3. PRODUCT PORTFOLIO
10.12.4. RECENT DEVELOPMENTS
11. RELATED REPORTS
LIST OF TABLE :
Table 1 GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 2 GLOBAL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 3 GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 4 GLOBAL IN SITU HYBRIDIZATION MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 5 GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 6 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 7 GLOBAL DNA MICROARRAYS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 8 GLOBAL FLOW CYTOMETRY MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 9 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 10 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING BY REGION, 2015– 2024 (USD MILLION)
Table 11 GLOBAL INSTRUMENT BASED CNACER DIAGNOSTICS MARKET, BY BIOPSY , BY REGION, 2015– 2024 (USD MILLION)
Table 12 GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 13 WORLDWIDE LUNG CANCER INCIDENCES
Table 14 GLOBAL CANCER DIAGNOSTICS MARKET, LUNG CANCER, BYREGION, 2015 – 2024 (USD MILLION)
Table 15 WORLDWIDE BREAST CANCER INCIDENCES
Table 16 GLOBAL CANCER DIAGNOSTICS MARKET, BY BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION)
Table 17 WORLDWIDE COLORECTAL CANCER INCIDENCES
Table 18 GLOBAL CANCER DIAGNOSTICS MARKET, BY COLORECTAL CANCER, BY REGION, 2015 – 2024 (USD MILLION)
Table 19 WORLDWIDE MELANOMA CANCER INCIDENCES
Table 20 GLOBAL CANCER DIAGNOSTICS MARKET, BY MELANOMA , BY REGION2015 – 2024 (USD MILLION)
Table 21 ESTIMATED NEW CASES OF CANCER IN 2017
Table 22 GLOBAL CANCER DIAGNOSTICS MARKET, BY OTHERS, BY REGION, 2015 – 2024 (USD MILLION)
Table 23 GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION)
Table 24 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 25 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 26 NORTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 27 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 28 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 29 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 30 U.S.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 31 U.S. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 32 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 33 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 34 U.S. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 35 CANADA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 36 CANADA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 37 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 38 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 39 CANADA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 40 MEXICO CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 41 MEXICO PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 42 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 43 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 44 MEXICO CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 45 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024(USD MILLION)
Table 46 EUROPE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 47 EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 48 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 49 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 50 EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 51 GERMANY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 52 GERMANY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 53 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 54 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 55 GERMANY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 56 FRANCE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 57 FRANCE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 58 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 59 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 60 FRANCE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 61 U.K.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 62 U.K. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 63 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 64 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 65 U.K. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 66 ITALY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 67 ITALY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 68 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 69 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 70 ITALY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 71 SPAIN CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 72 SPAIN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 73 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 74 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 75 SPAIN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 76 RUSSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 77 RUSSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 78 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 79 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 80 RUSSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 81 TURKEY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 82 TURKEY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 83 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 84 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 85 TURKEY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 86 BELGIUM CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 87 BELGIUM PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 88 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 89 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 90 BELGIUM CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 91 NETHERLANDSCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 92 NETHERLANDS PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 93 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 94 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 95 NETHERLANDS CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 96 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 97 SWITZERLAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 98 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 99 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 100 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 101 REST OF EUROPECANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 102 REST OF EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 103 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 104 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 105 REST OF EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 106 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 107 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 108 APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 109 APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 110 APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 111 APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 112 JAPANCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 113 JAPAN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 114 JAPAN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 115 JAPAN INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 116 JAPAN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 117 CHINA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 118 CHINA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 119 CHINA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 120 CHINA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 121 CHINA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 122 INDIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 123 INDIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 124 INDIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 125 INDIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 126 INDIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 127 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 128 SOUTH KOREA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 129 SOUTH KOREA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 130 SOUTH KOREA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 131 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 132 AUSTRALIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 133 AUSTRALIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 134 AUSTRALIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 135 AUSTRALIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 136 AUSTRALIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 137 THAILAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 138 THAILAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 139 THAILAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 140 THAILAND INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 141 THAILAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 142 SINGAPORE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 143 SINGAPORE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 144 SINGAPORE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 145 SINGAPORE INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 146 SINGAPORE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 147 MALAYSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 148 MALAYSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 149 MALAYSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 150 MALAYSIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 151 MALAYSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 152 INDONESIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 153 INDONESIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 154 INDONESIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 155 INDONESIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 156 INDONESIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 157 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 158 PHILLIPINES PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 159 PHILIPPINES INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 160 PHILIPPINES INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 161 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 162 REST OF APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 163 REST OF APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 164 REST OF APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 165 REST OF APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 166 REST OF APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 167 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 168 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 169 SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 170 SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 171 SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 172 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 173 BRAZIL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 174 BRAZIL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 175 BRAZIL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 176 BRAZIL INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 177 BRAZIL CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 178 REST OF SOUTH AMERICACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 179 REST OF SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 180 REST OF SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 181 REST OF SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 182 REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 183 MEA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 184 MEA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 185 MEA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 186 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 187 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 188 MEA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 189 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 190 SOUTH AFRICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 191 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 192 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 193 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 194 REST OF MEACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL CANCER DIAGNOSTICS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWTH OF AGING POPULATION AND RISING PREVALENCE OF CANCER
3.1.2. GOVERNMENT INITIATIVES FOR FUNDING AND AWARENESS ABOUT CANCER
3.1.3. KEY PLAYERS FOCUSING ON STRATEGIC DECISIONS TO GAIN MARKET SHARE
3.1.4. INCREASING PREVELANCE OF CANCER
3.2. RESTRAINTS
3.2.1. STRINGENT REULATIONS IMPOSED BY INTERNATIONAL AND LOCAL AUTHORITIES
3.2.2. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS
3.3. OPPORTUNITIES
3.3.1. NANOTECHNOLOGY: FORTHCOMING REVOLUTION IN CANCER DIAGNOSIS
3.3.2. ARTIFICIAL INTELLIGENCE AND THE IMMINENT HEALTH REVOLUTION
3.3.3. GROWING MEDICAL TOURISM IN ASIA
3.4. CHALLENGES
3.4.1. INCREASING RIVALRY AMONG THE COMPETITORS
3.4.2. POOR ACCESS TO CANCER DETECTION AND HIGH TREATMENT COCTS IN LOWER INCOME COUNTRIES
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.2. PLATFORM BASED
6.2.1. POLYMERASE CHAIN REACTION(PCR)
6.2.2. IN SITU HYBRIDIZATION (ISH)
6.2.3. IMMUNOHISTOCHEMISTRY(IHC)
6.2.4. NEXT GENERATION SEQUENCING (NGS)
6.2.5. DNA MICROARRAYS
6.2.6. FLOW CYTOMETRY
6.3. INSTRUMENT BASED
6.3.1. IMAGING
6.3.1.1. MAGENTIC RESONANCE IMAGING (MRI)
6.3.1.2. CT(COMPUTED TOMOGRAPHY)
6.3.1.3. POSITRON EMISSION TOMOGRAPHY- COMPUTED TOMOGRAPHY (PET-CT)
6.3.1.4. MAMMOGRAPHY
6.3.1.5. ULTRASOUND
6.3.2. BIOPSY
7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
7.5. MELANOMA
7.6. OTHERS
8. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET
8.2.1. U.S.CANCER DIAGNOSTICS MARKET
8.2.2. CANADA CANCER DIAGNOSTICS MARKET
8.2.3. MEXICO CANCER DIAGNOSTICS MARKET
8.3. EUROPE CANCER DIAGNOSTICS MARKET
8.3.1. GERMANY CANCER DIAGNOSTICS MARKET
8.3.2. FRANCE CANCER DIAGNOSTICS MARKET
8.3.3. U.K. CANCER DIAGNOSTICS MARKET
8.3.4. ITALY CANCER DIAGNOSTICS MARKET
8.3.5. SPAIN CANCER DIAGNOSTICS MARKET
8.3.6. RUSSIA CANCER DIAGNOSTICS MARKET
8.3.7. TURKEY CANCER DIAGNOSTICS MARKET
8.3.8. BELGIUM CANCER DIAGNOSTICS MARKET
8.3.9. NETHERLANDS CANCER DIAGNOSTICS MARKET
8.3.10. SWITZERLAND CANCER DIAGNOSTICS MARKET
8.3.11. REST OF EUROPE CANCER DIAGNOSTICS MARKET
8.4. APAC CANCER DIAGNOSTICS MARKET
8.4.1. JAPAN CANCER DIAGNOSTICS MARKET
8.4.2. CHINA CANCER DIAGNOSTICS MARKET
8.4.3. INDIA CANCER DIAGNOSTICS MARKET
8.4.4. SOUTH KOREA CANCER DIAGNOSTICS MARKET
8.4.5. AUSTRALIA CANCER DIAGNOSTICS MARKET
8.4.6. THAILAND CANCER DIAGNOSTICS MARKET
8.4.7. SINGAPORE CANCER DIAGNOSTICS MARKET
8.4.8. MALAYSIA CANCER DIAGNOSTICS MARKET
8.4.9. INDONESIA CANCER DIAGNOSTICS MARKET
8.4.10. PHILIPPINES CANCER DIAGNOSTICS MARKET
8.4.11. REST OF APAC CANCER DIAGNOSTICS MARKET
8.5. SOUTH AMERICA CANCER DIAGNOSTICS MARKET
8.5.1. BRAZIL CANCER DIAGNOSTICS MARKET
8.5.2. REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET
8.6. MEA CANCER DIAGNOSTICS MARKET
8.6.1. SOUTH AFRICA CANCER DIAGNOSTICS MARKET
8.6.2. REST OF MEA CANCER DIAGNOSTICS MARKET
9. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE
9.1. COMPANY SHARE ANALYSIS: GLOBAL CANCER DIAGNOSTICS IMAGING MARKET
9.2. COMPANY SHARE ANALYSIS: GLOBAL CANCER DIAGNOSTICS PLATFORM BASED MARKET
10. COMPANY PROFILES
10.1. C. R. BARD, INC.
10.1.1. COMPANY OVERVIEW
10.1.2. REVENUE ANALYSIS
10.1.3. PRODUCT PORTFOLIO
10.1.4. RECENT DEVELOPMENTS
10.2. ILLUMINA, INC.
10.2.1. COMPANY OVERVIEW
10.2.2. REVENUE ANALYSIS
10.2.3. RECENT DEVELOPMENTS
10.2.4. PRODUCT PORTFOLIO
10.3. QIAGEN
10.3.1. COMPANY OVERVIEW
10.3.2. REVENUE ANALYSIS
10.3.3. RECENT DEVELOPMENTS
10.3.4. PRODUCT PORTFOLIO
10.4. ABBOTT
10.4.1. COMPANY OVERVIEW
10.4.2. REVENUE ANALYSIS
10.4.3. RECENT DEVELOPMENTS
10.4.4. PRODUCT PORTFOLIO
10.5. SIEMENS HEALTHCARE GMBH
10.5.1. COMPANY OVERVIEW
10.5.2. REVENUE ANALYSIS
10.5.3. RECENT DEVELOPMENTS
10.5.4. PRODUCT PORTFOLIO
10.6. AGILENT TECHNOLOGIES
10.6.1. COMPANY OVERVIEW
10.6.2. REVENUE ANALYSIS
10.6.3. PRODUCT PORTFOLIO
10.6.4. RECENT DEVELOPMENTS
10.7. THERMO FISHER SCIENTIFIC INC.
10.7.1. COMPANY OVERVIEW
10.7.2. REVENUE ANALYSIS
10.7.3. PRODUCT PORTFOLIO
10.7.4. RECENT DEVELOPMENTS
10.8. BECTON, DICKINSON AND COMPANY
10.8.1. COMPANY OVERVIEW
10.8.2. REVENUE ANALYSIS
10.8.3. PRODUCT PORTFOLIO
10.8.4. RECENT DEVELOPMENTS
10.9. GE HEALTHCARE
10.9.1. COMPANY OVERVIEW
10.9.2. REVENUE ANALYSIS
10.9.3. PRODUCT PORTFOLIO
10.9.4. RECENT DEVELOPMENTS
10.10. F. HOFFMANN-LA ROCHE LTD
10.10.1. COMPANY OVERVIEW
10.10.2. REVENUE ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. RECENT DEVELOPMENTS
10.11. HOLOGIC INC.
10.11.1. COMPANY OVERVIEW
10.11.2. REVENUE ANALYSIS
10.11.3. RECENT DEVELOPMENTS
10.11.4. PRODUCT PORTFOLIO
10.12. KONINKLIJHE PHILIPS N.V.
10.12.1. COMPANY OVERVIEW
10.12.2. REVENUE ANALYSIS
10.12.3. PRODUCT PORTFOLIO
10.12.4. RECENT DEVELOPMENTS
11. RELATED REPORTS
LIST OF TABLE :
Table 1 GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 2 GLOBAL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 3 GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 4 GLOBAL IN SITU HYBRIDIZATION MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 5 GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 6 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 7 GLOBAL DNA MICROARRAYS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 8 GLOBAL FLOW CYTOMETRY MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 9 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 10 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING BY REGION, 2015– 2024 (USD MILLION)
Table 11 GLOBAL INSTRUMENT BASED CNACER DIAGNOSTICS MARKET, BY BIOPSY , BY REGION, 2015– 2024 (USD MILLION)
Table 12 GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 13 WORLDWIDE LUNG CANCER INCIDENCES
Table 14 GLOBAL CANCER DIAGNOSTICS MARKET, LUNG CANCER, BYREGION, 2015 – 2024 (USD MILLION)
Table 15 WORLDWIDE BREAST CANCER INCIDENCES
Table 16 GLOBAL CANCER DIAGNOSTICS MARKET, BY BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION)
Table 17 WORLDWIDE COLORECTAL CANCER INCIDENCES
Table 18 GLOBAL CANCER DIAGNOSTICS MARKET, BY COLORECTAL CANCER, BY REGION, 2015 – 2024 (USD MILLION)
Table 19 WORLDWIDE MELANOMA CANCER INCIDENCES
Table 20 GLOBAL CANCER DIAGNOSTICS MARKET, BY MELANOMA , BY REGION2015 – 2024 (USD MILLION)
Table 21 ESTIMATED NEW CASES OF CANCER IN 2017
Table 22 GLOBAL CANCER DIAGNOSTICS MARKET, BY OTHERS, BY REGION, 2015 – 2024 (USD MILLION)
Table 23 GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION)
Table 24 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 25 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 26 NORTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 27 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 28 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 29 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 30 U.S.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 31 U.S. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 32 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 33 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 34 U.S. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 35 CANADA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 36 CANADA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 37 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 38 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 39 CANADA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 40 MEXICO CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 41 MEXICO PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 42 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 43 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 44 MEXICO CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 45 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024(USD MILLION)
Table 46 EUROPE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 47 EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 48 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 49 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 50 EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 51 GERMANY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 52 GERMANY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 53 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 54 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 55 GERMANY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 56 FRANCE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 57 FRANCE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 58 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 59 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 60 FRANCE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 61 U.K.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 62 U.K. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 63 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 64 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 65 U.K. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 66 ITALY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 67 ITALY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 68 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 69 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 70 ITALY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 71 SPAIN CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 72 SPAIN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 73 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 74 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 75 SPAIN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 76 RUSSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 77 RUSSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 78 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 79 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 80 RUSSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 81 TURKEY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 82 TURKEY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 83 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 84 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 85 TURKEY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 86 BELGIUM CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 87 BELGIUM PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 88 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 89 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 90 BELGIUM CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 91 NETHERLANDSCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 92 NETHERLANDS PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 93 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 94 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 95 NETHERLANDS CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 96 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 97 SWITZERLAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 98 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 99 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 100 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 101 REST OF EUROPECANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 102 REST OF EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 103 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 104 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 105 REST OF EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 106 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 107 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 108 APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 109 APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 110 APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 111 APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 112 JAPANCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 113 JAPAN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 114 JAPAN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 115 JAPAN INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 116 JAPAN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 117 CHINA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 118 CHINA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 119 CHINA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 120 CHINA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 121 CHINA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 122 INDIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 123 INDIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 124 INDIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 125 INDIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 126 INDIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 127 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 128 SOUTH KOREA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 129 SOUTH KOREA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 130 SOUTH KOREA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 131 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 132 AUSTRALIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 133 AUSTRALIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 134 AUSTRALIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 135 AUSTRALIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 136 AUSTRALIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 137 THAILAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 138 THAILAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 139 THAILAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 140 THAILAND INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 141 THAILAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 142 SINGAPORE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 143 SINGAPORE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 144 SINGAPORE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 145 SINGAPORE INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 146 SINGAPORE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 147 MALAYSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 148 MALAYSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 149 MALAYSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 150 MALAYSIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 151 MALAYSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 152 INDONESIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 153 INDONESIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 154 INDONESIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 155 INDONESIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 156 INDONESIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 157 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 158 PHILLIPINES PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 159 PHILIPPINES INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 160 PHILIPPINES INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 161 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 162 REST OF APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 163 REST OF APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 164 REST OF APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 165 REST OF APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 166 REST OF APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 167 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 168 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 169 SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 170 SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 171 SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 172 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 173 BRAZIL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 174 BRAZIL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 175 BRAZIL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 176 BRAZIL INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 177 BRAZIL CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 178 REST OF SOUTH AMERICACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 179 REST OF SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 180 REST OF SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 181 REST OF SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 182 REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 183 MEA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 184 MEA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 185 MEA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 186 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 187 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 188 MEA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 189 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 190 SOUTH AFRICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 191 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 192 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 193 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 194 REST OF MEACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
LIST OF FIGURES
Figure 1 GLOBAL CANCER DIAGNOSTICS MARKET: SEGMENTATIO
Figure 2 GLOBAL CANCER DIAGNOSTICS MARKET: GEOGRAHIC SCOP
Figure 3 GLOBAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATIO
Figure 4 GLOBAL CANCER DIAGNOSTICS MARKET: SNAPSHOT
Figure 5 GLOBAL CANCER DIAGNOSTICS MARKET: BOTTOM UP APPROACH
Figure 6 GLOBAL CANCER DIAGNOSTICS MARKET: TOP DOWN APPROACH
Figure 7 GLOBAL CANCER DIAGNOSTICS MARKET: INTERVIEWS BY REGION AND DESIGNATION
Figure 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CANCER DIAGNOSTICS MARKET
Figure 9 POPULATION AGED OVER 60 (MILLIONS) (2010 VS 2050)
Figure 10 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTICS IMAGING SYSTEMS AND GROWING NUMBER OF CANCER PATIENTS IS EXPECTED TO DRIVE THE MARKET FOR CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 2017 TO 2024
Figure 11 INSTRUMENT BASED MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CANCER DIAGNOSTICS MARKET IN 2017
Figure 12 ASIA-PACIFIC AND SOUTH AMERICA ARE THE HIGHEST GROWING AND MOST PROFITable REVENUE POCKETS FOR CANCER DIAGNOSTICS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024
Figure 13 NORTH AMERICA DOMINATES THE MARKET FOR CANCER DIAGNOSTICS IN 2016 AND IS EXPECTED TO CONTINUE THIS TREND IN THE FORECAST PERIOD TO 2024
Figure 14 GLOBAL CANCER DIAGNOSTICS MARKET,SEGMENTATION: BY TECHNNOLOGY
Figure 15 GLOBAL CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, SNAPSHOT 2016
Figure 16 GLOBAL CANCER DIAGNOSTICSMARKET: BY APPLICATION, SNAPSHOT 2016
Figure 17 NORTH AMERICA CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 18 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 19 NORTH AMERICA CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 20 NORTH AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 21 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 22 EUROPEAN UNION POPULATION AGES 65 AND ABOVE (% OF TOTAL)
Figure 23 EUROPE CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 24 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 25 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2017)
Figure 26 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 27 EUROPE CANCER DIAGNOSTICS MARKET BY TECHNOLOGY (2017 & 2024)
Figure 28 APAC CANCER DIAGNOSTICS MARKET : SNAPSHOT (2017)
Figure 29 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 30 APAC CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 31 APAC CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 32 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 33 SOUTH AMERICA CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 34 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 35 SOUTH AMERICA CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 36 SOUTH AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 37 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 38 MEA CANCER DIAGNOSTICS MARKET: SNAPSHOT (2017)
Figure 39 MEA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 40 MEA CANCER DIAGNOSTICS MARKET: BY COUNTRY (2017)
Figure 41 MEA CANCER DIAGNOSTICS MARKET: BY COUNTRY (2016 & 2024)
Figure 42 MEA CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY (2016 & 2024)
Figure 43 GLOBAL CANCER DIAGNOSTICS MARKET: BY IMAGING, COMPANY SHARE 2016 (%)
Figure 44 GLOBAL CANCER DIAGNOSTICS MARKET: BY PLATFORM BASED, COMPANY SHARE 2016 (%)
Figure 1 GLOBAL CANCER DIAGNOSTICS MARKET: SEGMENTATIO
Figure 2 GLOBAL CANCER DIAGNOSTICS MARKET: GEOGRAHIC SCOP
Figure 3 GLOBAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATIO
Figure 4 GLOBAL CANCER DIAGNOSTICS MARKET: SNAPSHOT
Figure 5 GLOBAL CANCER DIAGNOSTICS MARKET: BOTTOM UP APPROACH
Figure 6 GLOBAL CANCER DIAGNOSTICS MARKET: TOP DOWN APPROACH
Figure 7 GLOBAL CANCER DIAGNOSTICS MARKET: INTERVIEWS BY REGION AND DESIGNATION
Figure 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CANCER DIAGNOSTICS MARKET
Figure 9 POPULATION AGED OVER 60 (MILLIONS) (2010 VS 2050)
Figure 10 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTICS IMAGING SYSTEMS AND GROWING NUMBER OF CANCER PATIENTS IS EXPECTED TO DRIVE THE MARKET FOR CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 2017 TO 2024
Figure 11 INSTRUMENT BASED MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CANCER DIAGNOSTICS MARKET IN 2017
Figure 12 ASIA-PACIFIC AND SOUTH AMERICA ARE THE HIGHEST GROWING AND MOST PROFITable REVENUE POCKETS FOR CANCER DIAGNOSTICS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024
Figure 13 NORTH AMERICA DOMINATES THE MARKET FOR CANCER DIAGNOSTICS IN 2016 AND IS EXPECTED TO CONTINUE THIS TREND IN THE FORECAST PERIOD TO 2024
Figure 14 GLOBAL CANCER DIAGNOSTICS MARKET,SEGMENTATION: BY TECHNNOLOGY
Figure 15 GLOBAL CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, SNAPSHOT 2016
Figure 16 GLOBAL CANCER DIAGNOSTICSMARKET: BY APPLICATION, SNAPSHOT 2016
Figure 17 NORTH AMERICA CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 18 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 19 NORTH AMERICA CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 20 NORTH AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 21 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 22 EUROPEAN UNION POPULATION AGES 65 AND ABOVE (% OF TOTAL)
Figure 23 EUROPE CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 24 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 25 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2017)
Figure 26 EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 27 EUROPE CANCER DIAGNOSTICS MARKET BY TECHNOLOGY (2017 & 2024)
Figure 28 APAC CANCER DIAGNOSTICS MARKET : SNAPSHOT (2017)
Figure 29 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 30 APAC CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 31 APAC CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 32 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 33 SOUTH AMERICA CANCER DIAGNOSTICS MARKET SNAPSHOT (2017)
Figure 34 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 35 SOUTH AMERICA CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 36 SOUTH AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 37 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)
Figure 38 MEA CANCER DIAGNOSTICS MARKET: SNAPSHOT (2017)
Figure 39 MEA CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 40 MEA CANCER DIAGNOSTICS MARKET: BY COUNTRY (2017)
Figure 41 MEA CANCER DIAGNOSTICS MARKET: BY COUNTRY (2016 & 2024)
Figure 42 MEA CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY (2016 & 2024)
Figure 43 GLOBAL CANCER DIAGNOSTICS MARKET: BY IMAGING, COMPANY SHARE 2016 (%)
Figure 44 GLOBAL CANCER DIAGNOSTICS MARKET: BY PLATFORM BASED, COMPANY SHARE 2016 (%)
